{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:54:12Z","timestamp":1790646852255,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jhepr.2026.101777","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:43:51Z","timestamp":1771605831000},"page":"101777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of sex on chemotherapy toxicity and efficacy in biliary tract cancer: Analysis of ABC, BILCAP trials and population data"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4728-7013","authenticated-orcid":false,"given":"Anna D.","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1405-7337","authenticated-orcid":false,"given":"Andre","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6669-9411","authenticated-orcid":false,"given":"Pinkie","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan W.","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2069-7605","authenticated-orcid":false,"given":"John","family":"Primrose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Twelves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6759-4701","authenticated-orcid":false,"given":"Luke","family":"Steventon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8787-4904","authenticated-orcid":false,"given":"David","family":"Dodwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bridgewater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10250","key":"10.1016\/j.jhepr.2026.101777_bib1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","article-title":"Sex and gender: modifiers of health, disease, and medicine","volume":"396","author":"Mauvais-Jarvis","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2026.101777_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejca.2017.07.013","article-title":"Sex differences in cancer risk and survival: a Swedish cohort study","volume":"84","author":"Radkiewicz","year":"2017","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.jhepr.2026.101777_bib3","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1158\/1055-9965.EPI-20-0036","article-title":"Sex differences in cancer incidence and survival: a pan-cancer analysis","volume":"29","author":"Dong","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"10.1016\/j.jhepr.2026.101777_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.jhepr.2026.101777_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/hepr.12605","article-title":"Sex-specific and race\/ethnicity-specific disparities in cholangiocarcinoma incidence and prevalence in the USA: an updated analysis of the 2000-2011 Surveillance, Epidemiology and End Results registry","volume":"46","author":"Mosadeghi","year":"2016","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101777_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CEJ.0000000000000402","article-title":"The incidence rates and survival of gallbladder cancer in the USA","volume":"28","author":"Jaruvongvanich","year":"2019","journal-title":"Eur J Cancer Prev"},{"issue":"5","key":"10.1016\/j.jhepr.2026.101777_bib7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.14309\/ajg.0000000000001151","article-title":"Trends in the mortality of biliary tract cancers based on their anatomical site in the United States from 2009 to 2018","volume":"116","author":"Kim","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.jhepr.2026.101777_bib8","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1158\/1055-9965.EPI-21-0265","article-title":"Incidence and mortality of cancers of the biliary tract, gallbladder, and liver by sex, age, race\/ethnicity, and stage at diagnosis: United States, 2013 to 2017","volume":"30","author":"Ellington","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101777_bib9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/annonc\/mdn533","article-title":"Epidemiology of biliary tract cancers: an update","volume":"20","author":"Randi","year":"2009","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101777_bib10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jhep.2020.04.046","article-title":"Associations between reproductive factors and biliary tract cancers in women from the Biliary Tract Cancers Pooling Project","volume":"73","author":"Jackson","year":"2020","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2026.101777_bib11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc.2016.30","article-title":"Sexual dimorphism in cancer","volume":"16","author":"Clocchiatti","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101777_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13293-020-00291-x","article-title":"Sex differences in cancer mechanisms","volume":"11","author":"Rubin","year":"2020","journal-title":"Biol Sex Differ"},{"issue":"5","key":"10.1016\/j.jhepr.2026.101777_bib13","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2016.04.001","article-title":"Comprehensive characterization of molecular differences in cancer between male and female patients","volume":"29","author":"Yuan","year":"2016","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.jhepr.2026.101777_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41568-021-00348-y","article-title":"Sex disparities matter in cancer development and therapy","volume":"21","author":"Haupt","year":"2021","journal-title":"Nat Rev Cancer"},{"issue":"13","key":"10.1016\/j.jhepr.2026.101777_bib15","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1245\/s10434-016-5448-0","article-title":"Sex disparity in gastric cancer: female sex is a poor prognostic factor for advanced gastric cancer","volume":"23","author":"Kim","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101777_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00423-019-01850-6","article-title":"Gender comparison of clinical, histopathological, therapeutic and outcome factors in 185,967 colon cancer patients","volume":"405","author":"Schmuck","year":"2020","journal-title":"Langenbecks Arch Surg"},{"issue":"12","key":"10.1016\/j.jhepr.2026.101777_bib17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","article-title":"Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies","volume":"16","author":"Keum","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.101777_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.607909","article-title":"Sexual dimorphism in colon cancer","volume":"10","author":"Abancens","year":"2020","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.jhepr.2026.101777_bib19","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1124\/pharmrev.120.000206","article-title":"Sex- and gender-based pharmacological response to drugs","volume":"73","author":"Mauvais-Jarvis","year":"2021","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jhepr.2026.101777_bib20","first-page":"JCO2102377","article-title":"Sex differences in risk of severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in cancer clinical trials","author":"Unger","year":"2022","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101777_bib21","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1200\/JCO.2005.03.171","article-title":"Influence of sex on toxicity and treatment outcome in small-cell lung cancer","volume":"23","author":"Singh","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jhepr.2026.101777_bib22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ncponc1124","article-title":"Differences in hematotoxicity between male and female patients with Hodgkin lymphoma and other malignancies","volume":"5","author":"Klimm","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"issue":"16","key":"10.1016\/j.jhepr.2026.101777_bib23","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.ejca.2015.06.123","article-title":"Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial","volume":"51","author":"van den Berg","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jhepr.2026.101777_bib24","article-title":"Sex and adverse events of adjuvant chemotherapy in colon cancer: an analysis of 34,640 patients in the ACCENT database","author":"Wagner","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.jhepr.2026.101777_bib25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.jhepr.2026.101777_bib26","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine vs. gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2026.101777_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12885-016-2174-8","article-title":"A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study","volume":"16","author":"Bridgewater","year":"2016","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.jhepr.2026.101777_bib28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1470-2045(15)00139-4","article-title":"Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial","volume":"16","author":"Valle","year":"2015","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101777_bib29","article-title":"Data Resource profile: the systemic anti-cancer therapy (SACT) dataset","volume":"49","author":"Bright","year":"2020","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101777_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyz076","article-title":"Data Resource profile: national cancer registration dataset in England","volume":"49","author":"Henson","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101777_bib31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1200\/JCO.1999.17.1.409","article-title":"Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin","volume":"17","author":"Go","year":"1999","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jhepr.2026.101777_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ph15020255","article-title":"Gender and sex-related differences in normal tissue effects induced by platinum compounds","volume":"15","author":"Marcu","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jhepr.2026.101777_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/abr.abr_124_17","article-title":"Cisplatin alters sodium excretion and renal clearance in rats: gender and drug dose related","volume":"7","author":"Jilanchi","year":"2018","journal-title":"Adv Biomed Res"},{"issue":"5","key":"10.1016\/j.jhepr.2026.101777_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/01243894-200606000-00011","article-title":"Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594","volume":"1","author":"Wakelee","year":"2006","journal-title":"J Thorac Oncol"},{"issue":"19","key":"10.1016\/j.jhepr.2026.101777_bib35","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.7150\/jca.20083","article-title":"Cisplatin nephrotoxicity might have a sex difference. An analysis based on women's sex hormone changes","volume":"8","author":"Chen","year":"2017","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101777_bib36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/pbc.24138","article-title":"Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients","volume":"59","author":"Yancey","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.jhepr.2026.101777_bib37","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/jnci\/djaa124","article-title":"Sex and adverse events of adjuvant chemotherapy in colon cancer: an analysis of 34 640 patients in the ACCENT database","volume":"113","author":"Wagner","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.jhepr.2026.101777_bib38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00280-012-2007-7","article-title":"Comparison of pharmacokinetics and safety profiles of two capecitabine tablet formulations in patients with colon, colorectal or breast cancer","volume":"71","author":"Chachad","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"10.1016\/j.jhepr.2026.101777_bib39","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/cncr.22815","article-title":"Recent trends of gallbladder cancer in Japan: an analysis of 4,770 patients","volume":"110","author":"Kayahara","year":"2007","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jhepr.2026.101777_bib40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5114\/ceh.2019.85166","article-title":"Epidemiology of gallbladder cancer","volume":"5","author":"Rawla","year":"2019","journal-title":"Clin Exp Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101777_bib41","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/s12885-015-1498-0","article-title":"Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial","volume":"15","author":"Stein","year":"2015","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101777_bib42","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1038\/s41467-020-17359-2","article-title":"Sex differences in oncogenic mutational processes","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"issue":"Suppl 4","key":"10.1016\/j.jhepr.2026.101777_bib43","article-title":"Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer","volume":"5","author":"Mederos","year":"2020","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.jhepr.2026.101777_bib44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13293-020-00308-5","article-title":"Sex differences in pharmacokinetics predict adverse drug reactions in women","volume":"11","author":"Zucker","year":"2020","journal-title":"Biol Sex Differ"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926000480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926000480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T01:50:05Z","timestamp":1779414605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555926000480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2589555926000480"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101777","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of sex on chemotherapy toxicity and efficacy in biliary tract cancer: Analysis of ABC, BILCAP trials and population data","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101777","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101777"}}